EFFECTS OF SODIUM THIOSULFATE VERSUS OBSERVATION ON DEVELOPMENT OF CISPLATIN-INDUCED HEARING LOSS IN CHILDREN WITH CANCER: RESULTS FROM THE CHILDREN’S ONCOLOGY GROUP ACCL0431 RANDOMISED CLINICAL TRIAL

BACKGROUND: Sodium thiosulfate (STS) is an antioxidant shown in preclinical studies to prevent cisplatin-induced hearing loss (CIHL) but not compromise anti-tumour efficacy with timed administration post-cisplatin. The primary study aim was to evaluate STS for prevention of CIHL. METHODS: ACCL0431 w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Lancet Oncol
Huvudupphovsmän: Freyer, David R., Chen, Lu, Krailo, Mark D., Knight, Kristin, Villaluna, Doojduen, Bliss, Bonnie, Pollock, Brad H., Ramdas, Jagadeesh, Lange, Beverly, Van Hoff, David, VanSoelen, Michele L., Wiernikowski, John, Neuwelt, Edward A., Sung, Lillian
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520988/
https://ncbi.nlm.nih.gov/pubmed/27914822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30625-8
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk